Skip to content
Home/Companies/Pharma/OcuMension
OcuMension

OcuMension

Pharma·USA·Active
Entry
–
Hold
–
Status
Active

Who owns OcuMension?

OcuMension is an American Pharma company, currently owned by General Atlantic.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
General Atlantic
Investor
General Atlantic
Fund attribution unclassified.

Key facts

HQUSA
SectorPharma
Websitewww.ocumension.com

More from General Atlantic Portfolio

Other portfolio companies in the same fund.

Aceco TI
Active
SoftwareBrazil
Aces
Aces
Active
Affinion Group
Active
Business ServicesUK
Alibaba
Active
E-commerceChina
Align Networks
Active
SoftwareUS
Alternate Solutions Health Network
Alternate Solutions Health Network
Active
HealthcareUS

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns OcuMension?

OcuMension is currently owned by General Atlantic.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue